The authors would like to make 2 corrections in the publication of the review article. The following are the corrected table and figure:
- On page 255 (Table 2), the authors make the correction below on the definition of Very High Risk (VHR):
|
Original |
Correction |
|
Authors recommend defining a VHR category as follows: • Clinical: Presence of any of the following—recent fragility fracture in the last 1 year; history of multiple previous fragility fractures; more than 2 fragility fractures while on treatment; T-score ≤-3.0; high fall risk; or long-term use of bone-harming medications. |
Authors recommend defining a VHR category as follows: • Clinical: Presence of any of the following—recent fragility fracture in the last 1 year; history of multiple previous fragility fractures; more than 2 fragility fractures while on treatment; T-score ≤-3.0; low BMD with high fall risk or long-term use of bone-harming medications. |
- On page 263 (Fig. 1), the authors make the same correction to the definition of VHR;
Original:
Very High Fracture Risk
• Clinical: Presence of any of the following—recent fragility fracture in the last 1 year, history of multiple previous fragility fractures, more than 2 fragility fractures while on treatment, T-score ≤-3.0, high fall risk, or long-term use of bone-harming medications.
Correction:
Very High Fracture Risk
• Clinical: Presence of any of the following—recent fragility fracture in the last 1 year, history of multiple previous fragility fractures, more than 2 fragility fractures while on treatment, T-score ≤-3.0, low BMD with high fall risk or long-term use of bone-harming medications.
The authors would like to apologise for any inconvenience caused.
The authors declare they have no affiliations or financial involvement with any commercial organisation with a direct financial interest in the subject or materials discussed in the manuscript.
